Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

579 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Biomarkers of platelet activation and cardiovascular risk in the DAPT trial.
Berg DD, Yeh RW, Mauri L, Morrow DA, Kereiakes DJ, Cutlip DE, Gao Q, Jarolim P, Michelson AD, Frelinger AL 3rd, Cange AL, Sabatine MS, O'Donoghue ML. Berg DD, et al. Among authors: kereiakes dj. J Thromb Thrombolysis. 2021 Apr;51(3):675-681. doi: 10.1007/s11239-020-02221-5. J Thromb Thrombolysis. 2021. PMID: 32683645 Clinical Trial.
High platelet count in platelet-rich plasma reduces measured platelet inhibition by abciximab but not tirofiban nor eptifibatide glycoprotein IIb/IIIa receptor antagonists.
Kereiakes DJ, Broderick TM, Roth EM, Whang D, Mueller M, Lacock P, Anderson LC, Howard W, Blanck C, Schneider J, Abbottsmith CA. Kereiakes DJ, et al. J Thromb Thrombolysis. 2000 Feb;9(2):149-55. doi: 10.1023/a:1018718914065. J Thromb Thrombolysis. 2000. PMID: 10613996 Clinical Trial.
Final results of a randomized trial comparing the NIR stent to the Palmaz-Schatz stent for narrowings in native coronary arteries.
Baim DS, Cutlip DE, O'Shaughnessy CD, Hermiller JB, Kereiakes DJ, Giambartolomei A, Katz S, Lansky AJ, Fitzpatrick M, Popma JJ, Ho KK, Leon MB, Kuntz RE; NIRVANA Investigators (NIR Vascular Advanced North American Trial). Baim DS, et al. Among authors: kereiakes dj. Am J Cardiol. 2001 Jan 15;87(2):152-6. doi: 10.1016/s0002-9149(00)01307-2. Am J Cardiol. 2001. PMID: 11152830 Clinical Trial.
Final results of a randomized trial comparing the MULTI-LINK stent with the Palmaz-Schatz stent for narrowings in native coronary arteries.
Baim DS, Cutlip DE, Midei M, Linnemeier TJ, Schreiber T, Cox D, Kereiakes D, Popma JJ, Robertson L, Prince R, Lansky AJ, Ho KK, Kuntz RE; ASCENT Invesigators (ACS MultLink Stent Clinical Equivalence in De Novo Lesions Trial). Baim DS, et al. Am J Cardiol. 2001 Jan 15;87(2):157-62. doi: 10.1016/s0002-9149(00)01308-4. Am J Cardiol. 2001. PMID: 11152831 Clinical Trial.
Leukocyte-platelet aggregation, platelet surface P-selectin, and platelet surface glycoprotein IIIa after percutaneous coronary intervention: Effects of dalteparin or unfractionated heparin in combination with abciximab.
Furman MI, Kereiakes DJ, Krueger LA, Mueller MN, Pieper K, Broderick TM, Schneider JF, Howard WL, Fox ML, Barnard MR, Frelinger AL 3rd, Michelson AD. Furman MI, et al. Among authors: kereiakes dj. Am Heart J. 2001 Nov;142(5):790-8. doi: 10.1067/mhj.2001.119128. Am Heart J. 2001. PMID: 11685164
579 results